Drug Trial Radar · NCT06265727
A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
Last checked: Nov 19, 2026Latest source record: Jan 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
348
Planned (sponsor's estimate)
Start
Apr 1, 2024
Primary completion
Jan 16, 2027
Study completion Jan 27, 2027
Sponsor
- Lead sponsor
- Corbus Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- Collaborators
- CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
- First posted
- Feb 20, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to define a safe and effective dose of CRB-701 for participants with solid tumors that are expressing a protein called nectin-4. The main questions it aims to answer are: What is the the safe and effective dose of CRB-701? What cancers can be treated effectively with CRB-701? Participants will be asked to attend clinic and be given a intravenous infusion of CRB-701. They will have blood tests, CT or MRI Scans, and other assessments to measure whether CRB-701 has an effect on tumors.
Conditions
- Solid Tumor, Adult
Interventions
CRB-701Drug
Nectin-4 targeted Antibody Drug Conjugate (ADC)
Anti-PD-1Drug
checkpoint inhibitor
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part A: To confirm the safety and tolerability and determine MTD and PADR for CRB-701Time frame: 21 days
- Part B & C: To evaluate efficacy in terms of Objective Response Rate (ORR)Time frame: Up to 6 months
Locations
41 sites in 7 countries. Site status is shown where the registry gives one.
O'Neal Comprehensive Cancer Center at University of Alabama-Birmingham
Birmingham, Alabama · Recruiting
City of Hope Cancer Center
Duarte, California · Recruiting
Moores Cancer Centre at UC San Diego Health
San Diego, California · Recruiting
Helen Diller Family Comprehensive Cancer Center - UCSF
San Francisco, California · Recruiting
Rocky Mountain Cancer Centres
Denver, Colorado · Active not recruiting
Yale Cancer Center
New Haven, Connecticut · Recruiting
Florida Cancer Specialists
Orlando, Florida · Recruiting
University of Chicago
Chicago, Illinois · Recruiting
Hope and Healing Cancer Center
Hinsdale, Illinois · Active not recruiting
Dana-Faber Cancer Institute
Boston, Massachusetts · Recruiting
Nebraska Hematology Oncology
Lincoln, Nebraska · Active not recruiting
Carolina BioOncology Institute
Huntersville, North Carolina · Active not recruiting
Texas Oncology
Tyler, Texas · Recruiting
Virginia Cancer Specialists
Fairfax, Virginia · Active not recruiting
Fred Hutchinson Cancer Center at University of Washington
Seattle, Washington · Recruiting
ICM-Val d'Aurelle
Montpellier, France · Recruiting
CHU de Poitiers
Poitiers, France · Recruiting
Institut de Cancerologie de l'Ouest
Saint-Herblain, France · Recruiting
Gustave Roussy
Villejuif, France · Recruiting
Careggi University Hospital
Florence, Italy · Recruiting
European Institute of Oncology IRCCS
Milan, Italy · Recruiting
Fondazione Policlinico Gemelli, IRCCS
Rome, Italy · Recruiting
Centro Richerche Cliniche di Verona
Verona, Italy · Recruiting
Institute of Oncology/ARENSIA Exploratory Medicine
Chisinau, Moldova · Withdrawn
Aresnsia Research Clinic Bucharest
Bucharest, Romania · Recruiting
Aresnsia Research Clinic Cluj-Napoca
Cluj-Napoca, Romania · Recruiting
Centrul de Oncologie Sf. Nectarie
Iași, Romania · Recruiting
Centrul de Oncologie Euroclinic
Iași, Romania · Recruiting
Barcelona IOB Hospital Quironsalud (NEXT)
Barcelona, Spain · Recruiting
Vall d-Hebron Institut d'Oncologia
Barcelona, Spain · Recruiting
Fundacion Jimenez Diaz (START)
Madrid, Spain · Recruiting
Hospital Clinico Universitario de Valencia
Valencia, Spain · Recruiting
University of Birmingham NHS Foundation Trust
Birmingham, United Kingdom · Recruiting
University of Cambridge NHS Foundation Trust
Cambridge, United Kingdom · Recruiting
Velindre Cancer Centre
Cardiff, United Kingdom · Recruiting
Leeds University Hospitals NHS Trust
Leeds, United Kingdom · Recruiting
Guy's and St Thomas' Clinical Research Facility
London, United Kingdom · Recruiting
Imperial Experimental Cancer Medicine Centre
London, United Kingdom · Recruiting
The Christie Hospital
Manchester, United Kingdom · Recruiting
University of Liverpool - Clatterbridge Medical Centre
Metropolitan Borough of Wirral, United Kingdom · Recruiting
Showing 40 of 41 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.